|
US3297709A
(en)
*
|
1965-11-19 |
1967-01-10 |
American Home Prod |
Certain substituted tetrazole derivatives
|
|
DE3607194A1
(de)
*
|
1986-03-05 |
1987-09-10 |
Merck Patent Gmbh |
Carbamoylphenothiazine
|
|
DE3633485A1
(de)
|
1986-10-02 |
1988-04-07 |
Bayer Ag |
Substituierte 2-pyri(mi)dyl-2'-pyridyl-(thio)-ether
|
|
FR2643371B1
(fr)
|
1989-02-17 |
1993-11-05 |
Roussel Uclaf |
Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments
|
|
EP0419683A4
(en)
|
1989-04-13 |
1992-03-11 |
Japan Tobacco Inc. |
New amino acid derivatives having prolylendopeptidase inhibitor activity
|
|
IT1232350B
(it)
|
1989-08-04 |
1992-01-28 |
Poli Ind Chimica Spa |
Nuovi ergolinici derivati dalla prolina e strutture correlate con attivita' dopaminergica.
|
|
AU643300B2
(en)
*
|
1990-06-07 |
1993-11-11 |
Zeria Pharmaceutical Co., Ltd. |
Novel arylalkanoylamine derivative and drug containing the same
|
|
JP2518965B2
(ja)
|
1990-09-21 |
1996-07-31 |
三井東圧化学株式会社 |
新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
|
|
IL100428A0
(en)
|
1990-12-21 |
1992-09-06 |
Ciba Geigy |
Pyrimidinyl-and triazinyl-salicylamides,their preparation and their use as herbicides and plant growth regulants
|
|
JPH05155771A
(ja)
|
1991-12-05 |
1993-06-22 |
Zeria Pharmaceut Co Ltd |
アリールアルカノイル誘導体を含有する後天性免疫不全症候群予防治療剤
|
|
DE4141399A1
(de)
|
1991-12-16 |
1993-06-17 |
Bayer Ag |
4-(substituierte)amino-3-arylpyrrolinon-derivate
|
|
PH31294A
(en)
*
|
1992-02-13 |
1998-07-06 |
Thomae Gmbh Dr K |
Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
|
|
DE4206041A1
(de)
*
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl-substituierte imidazolylpropensaeurederivate
|
|
DE4206045A1
(de)
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl substituierte pyridone
|
|
US5569662A
(en)
|
1992-03-23 |
1996-10-29 |
Pfizer Inc. |
Quinuclidine derivatives as substance P antagonists
|
|
US5254453A
(en)
*
|
1992-04-16 |
1993-10-19 |
Eastman Kodak Company |
Process for preparing narrow size distribution small tabular grains
|
|
CA2110500A1
(en)
*
|
1992-06-17 |
1993-12-23 |
Christoph Luthy |
Pyrimidinyl- and tetrazinyl compounds with herbicidal activity
|
|
AU4348993A
(en)
|
1992-06-19 |
1994-01-24 |
James Black Foundation Limited |
Bicyclooctane and bicycloheptane derivatives
|
|
EP0648213A1
(en)
*
|
1992-07-01 |
1995-04-19 |
Pfizer Inc. |
Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists
|
|
DE4301105A1
(de)
|
1993-01-18 |
1994-07-21 |
Agfa Gevaert Ag |
Farbfotografisches Aufzeichnungsmaterial
|
|
DE4301106A1
(de)
|
1993-01-18 |
1994-07-21 |
Agfa Gevaert Ag |
Farbfotografisches Aufzeichnungsmaterial
|
|
EP0714299B1
(en)
|
1993-07-16 |
2002-04-24 |
Merck & Co. Inc. |
Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
|
|
FR2711992A1
(fr)
|
1993-11-03 |
1995-05-12 |
Lipha |
Nouveaux dérivé hétérocycliques, procédé de préparation et composition pharmaceutique les contenant.
|
|
US5492916A
(en)
*
|
1993-12-23 |
1996-02-20 |
Merck & Co., Inc. |
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
US5492920A
(en)
*
|
1993-12-10 |
1996-02-20 |
Merck & Co., Inc. |
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
|
|
US5494919A
(en)
*
|
1993-11-09 |
1996-02-27 |
Merck & Co., Inc. |
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
IL111785A0
(en)
*
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
JPH07228529A
(ja)
*
|
1994-02-17 |
1995-08-29 |
Zeria Pharmaceut Co Ltd |
コリンエステラーゼ賦活剤
|
|
US5804560A
(en)
|
1995-01-06 |
1998-09-08 |
Sibia Neurosciences, Inc. |
Peptide and peptide analog protease inhibitors
|
|
AU4715896A
(en)
*
|
1995-02-13 |
1996-09-04 |
Bayer Aktiengesellschaft |
2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
|
|
JP3599403B2
(ja)
|
1995-02-24 |
2004-12-08 |
山之内製薬株式会社 |
ベンズアゼピン誘導体の新規製造法
|
|
US5795894A
(en)
|
1995-05-02 |
1998-08-18 |
Schering Corporation |
Piperazino derivatives as neurokinn antagonists
|
|
AU5762696A
(en)
|
1995-05-09 |
1996-11-29 |
Bayer Aktiengesellschaft |
Alkyl dihalogenated phenyl-substituted ketoenols useful as p esticides and herbicides
|
|
US5514505A
(en)
*
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
|
US5563014A
(en)
|
1995-05-15 |
1996-10-08 |
Xerox Corporation |
Migration imaging members
|
|
HUT76640A
(en)
*
|
1995-08-17 |
1997-10-28 |
Chinoin Gyogyszer Es Vegyeszet |
Compounds of pharmaceutical activity cyclic amide derivatives, pharmaceutical compositions containing them, process for producing them and their use
|
|
ES2158344T3
(es)
|
1995-09-13 |
2001-09-01 |
Takeda Chemical Industries Ltd |
Compuestos benzoxazepinicos, su produccion y uso como agentes reductores de lipidos.
|
|
US6057314A
(en)
*
|
1995-12-21 |
2000-05-02 |
Biochem Pharma Inc. |
Low molecular weight bicyclic thrombin inhibitors
|
|
NZ330216A
(en)
|
1996-01-16 |
2000-09-29 |
Bristol Myers Squibb Co |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
|
|
US5767097A
(en)
*
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
|
DE19613329A1
(de)
*
|
1996-04-03 |
1997-10-09 |
Hoechst Schering Agrevo Gmbh |
Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
|
TW397821B
(en)
|
1996-04-19 |
2000-07-11 |
American Home Produits Corp |
3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
|
|
US20020006899A1
(en)
*
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
AU2401697A
(en)
*
|
1996-06-20 |
1998-01-07 |
Pfizer Inc. |
4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
|
|
AU3359697A
(en)
|
1996-07-08 |
1998-02-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Bone resorption inhibitors
|
|
US5968929A
(en)
*
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
|
US6011155A
(en)
*
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
CN1225972C
(zh)
*
|
1996-12-19 |
2005-11-09 |
伊萨格罗股份公司 |
基于(n－苯乙酰基－n－2,6－二甲苯基)氨基丙酸甲酯的杀真菌组合物
|
|
US6500885B1
(en)
|
1997-02-28 |
2002-12-31 |
Candescent Technologies Corporation |
Polycarbonate-containing liquid chemical formulation and methods for making and using polycarbonate film
|
|
US6180698B1
(en)
*
|
1997-02-28 |
2001-01-30 |
Candescent Technologies Corporation |
Polycarbonate-containing liquid chemical formulation and method for making polycarbonate film
|
|
US5914150A
(en)
*
|
1997-02-28 |
1999-06-22 |
Candescent Technologies Corporation |
Formation of polycarbonate film with apertures determined by etching charged-particle tracks
|
|
US6319902B1
(en)
|
1997-08-22 |
2001-11-20 |
Shionogi & Co., Ltd. |
Peptide derivatives having thiazolyl-alanine residue
|
|
AU742040C
(en)
|
1997-09-24 |
2003-10-02 |
Amgen, Inc. |
Method for preventing and treating hearing loss using sensorineurotrophic compounds
|
|
EP2583675A1
(en)
|
1998-02-02 |
2013-04-24 |
Trustees Of Tufts College |
Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
|
|
US6583170B1
(en)
|
1998-05-15 |
2003-06-24 |
Wyeth |
2-Phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol and estrogen formulations
|
|
EA008723B1
(ru)
|
1998-06-03 |
2007-06-29 |
Джи-Пи-Ай Эн-Ай-Эл Холдингз, Инк. |
Аза-гетероциклические соединения, применяемые для лечения неврологических расстройств и выпадения волос
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
HUP0102532A3
(en)
*
|
1998-06-03 |
2002-06-28 |
Gpi Nil Holdings Inc Wilmingto |
Aza-heterocyclic compounds used to treat neurological disorders and hair loss and process for their preparation and pharmaceutical compositions containing them
|
|
IL140040A0
(en)
*
|
1998-06-03 |
2002-02-10 |
Guilford Pharm Inc |
N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
|
|
DE19826972A1
(de)
|
1998-06-18 |
1999-12-23 |
Univ Magdeburg Tech |
Verwendung von Enzyminhibitoren und pharmazeutische Zubereitung zur Therapie von dermatologischen Erkrankungen mit follikulären und epidermalen Hyperkeratosen und einer verstärkten Keratinozytenproliferation
|
|
US6337340B1
(en)
*
|
1998-08-14 |
2002-01-08 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
|
|
US20030176357A1
(en)
|
1998-10-06 |
2003-09-18 |
Pospisilik Andrew J. |
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
DE19959916A1
(de)
*
|
1998-12-30 |
2000-07-20 |
Henkel Chile Sa |
Füllstoffhaltige Polymerdispersion, Verfahren zu deren Herstellung und deren Verwendung
|
|
DE60021254T2
(de)
|
1999-03-15 |
2006-04-20 |
AXYS Pharmaceuticals, Inc., South San Francisco |
N-cyanomethylamide als protease inhibitoren
|
|
GB9906715D0
(en)
*
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
|
CA2369103A1
(en)
|
1999-04-09 |
2000-10-19 |
Meiji Seika Kaisha, Ltd. |
Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
|
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
|
GB2355457A
(en)
*
|
1999-09-30 |
2001-04-25 |
Merck & Co Inc |
Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists
|
|
CO5271670A1
(es)
|
1999-10-29 |
2003-04-30 |
Pfizer Prod Inc |
Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
|
|
US20040152745A1
(en)
|
1999-11-12 |
2004-08-05 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
|
GB9928330D0
(en)
*
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
EP1743655B1
(en)
|
2000-01-21 |
2014-06-25 |
Novartis AG |
Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
|
|
US7064145B2
(en)
|
2000-02-25 |
2006-06-20 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
|
KR20080067009A
(ko)
|
2000-03-31 |
2008-07-17 |
프로시디온 리미티드 |
디펩티딜 펩티다제 ⅳ 효소 활성 억제제를 포함하는약제학적 조성물
|
|
US20030073701A1
(en)
*
|
2001-03-31 |
2003-04-17 |
Thompson Lorin A. |
Succinoylamino heterocycles as inhibitors of a beta protein production
|
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
EP1278751A1
(en)
*
|
2000-05-01 |
2003-01-29 |
Bristol-Myers Squibb Pharma Company |
Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists
|
|
DE10025464A1
(de)
*
|
2000-05-23 |
2001-12-06 |
Inst Medizintechnologie Magdeb |
Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen
|
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
DE10029077A1
(de)
*
|
2000-06-13 |
2001-12-20 |
Bayer Ag |
Thiazolylsubstituierte Heterocyclen
|
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
|
US20020025952A1
(en)
*
|
2000-07-06 |
2002-02-28 |
American Home Products Corporation |
Combinations of statins, estrogens and estrogenic agents
|
|
US20020028792A1
(en)
*
|
2000-07-06 |
2002-03-07 |
American Home Products Corporation |
Combinations of bisphosphonates, estrogens and estrogenic agents
|
|
US6376486B1
(en)
|
2000-07-06 |
2002-04-23 |
American Home Products Corporation |
Methods of inhibiting sphincter incontinence
|
|
AR029539A1
(es)
*
|
2000-07-06 |
2003-07-02 |
Wyeth Corp |
Combinaciones de estatinas y agentes estrogenicos
|
|
US20020019373A1
(en)
*
|
2000-07-06 |
2002-02-14 |
American Home Products Corporation |
Combinations of bisphosphonates and estrogenic agents
|
|
US6369051B1
(en)
*
|
2000-07-06 |
2002-04-09 |
American Home Products Corporation |
Combinations of SSRI and estrogenic agents
|
|
WO2002003990A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted insole compounds for treating excessive intraocular pressure
|
|
WO2002003986A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating breast disorders
|
|
US6455568B2
(en)
*
|
2000-07-06 |
2002-09-24 |
Wyeth |
Combination therapy for inhibiting sphincter incontinence
|
|
US20020028800A1
(en)
*
|
2000-07-06 |
2002-03-07 |
American Home Products Corporation |
Combination therapy for prosthesis-related bone degeneration
|
|
AU2001273144A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Wyeth |
Use of substituted indole compounds for treating neuropeptide y-related conditions
|
|
AU7178301A
(en)
*
|
2000-07-06 |
2002-01-21 |
American Home Prod |
Methods for increasing nitric oxide synthase activity
|
|
JP4812225B2
(ja)
|
2000-07-11 |
2011-11-09 |
塩野義製薬株式会社 |
生理活性ペプチド含有腸溶性製剤
|
|
JP4101053B2
(ja)
|
2000-08-10 |
2008-06-11 |
田辺三菱製薬株式会社 |
プロリン誘導体及びその医薬用途
|
|
MXPA03001344A
(es)
*
|
2000-08-16 |
2004-04-05 |
Neurogen Corp |
Derivados de piridina 2,4-substituidos.
|
|
BR0114436A
(pt)
*
|
2000-10-06 |
2003-07-01 |
Tanabe Seiyaku Co |
Composto com anel de cinco elementos contendo nitrogênio alifático
|
|
US6518299B1
(en)
*
|
2000-10-20 |
2003-02-11 |
Biocryst Pharmaceuticals, Inc. |
Substituted pyrrolidine compounds useful as neuraminidase inhibitors
|
|
TWI243162B
(en)
*
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
|
CA2433090A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
DE10100053A1
(de)
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
|
CA2627862C
(en)
|
2001-01-02 |
2009-12-22 |
Imtm Gmbh |
Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
|
|
SK10802003A3
(sk)
*
|
2001-02-02 |
2004-05-04 |
Takeda Chemical Industries, Ltd. |
Kondenzovaná heterocyklická zlúčenina, jej použitie a jej farmaceutický prípravok
|
|
EP1368349B1
(de)
*
|
2001-02-24 |
2007-02-14 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
|
|
EP1370211A4
(en)
*
|
2001-03-02 |
2005-02-09 |
Bristol Myers Squibb Co |
SIMULTANEOUS ADMINISTRATION OF MELANOCORTIN RECEPTOR AGONISTS AND A PHOSPHODIESTERASE HEMMER FOR THE TREATMENT OF DISEASES RELATED TO CYCLIC AMP
|
|
CA2438272A1
(en)
*
|
2001-03-02 |
2002-10-10 |
John Macor |
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
|
|
JP2002265439A
(ja)
|
2001-03-08 |
2002-09-18 |
Mitsubishi Pharma Corp |
シアノピロリジン誘導体およびその医薬用途
|
|
FR2822826B1
(fr)
*
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US20030032625A1
(en)
*
|
2001-03-29 |
2003-02-13 |
Topo Target Aps |
Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors
|
|
GB0109146D0
(en)
|
2001-04-11 |
2001-05-30 |
Ferring Bv |
Treatment of type 2 diabetes
|
|
AU2002254567B2
(en)
*
|
2001-04-11 |
2007-10-11 |
Bristol-Myers Squibb Company |
Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
|
|
FR2824825B1
(fr)
*
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2005500270A
(ja)
|
2001-05-29 |
2005-01-06 |
ギルフォード ファーマシュウティカルズ インコーポレイテッド |
手術の結果として発生した神経損傷を治療するための方法
|
|
FR2825717B1
(fr)
|
2001-06-08 |
2005-02-18 |
Rhodia Chimie Sa |
Preparation stereoselective de l-acides amines cycliques
|
|
CA2450579A1
(en)
|
2001-06-20 |
2003-01-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
JP4357293B2
(ja)
|
2001-06-27 |
2009-11-04 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
|
US20030135023A1
(en)
|
2001-06-27 |
2003-07-17 |
Hans-Ulrich Demuth |
Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis
|
|
ATE380175T1
(de)
|
2001-06-27 |
2007-12-15 |
Smithkline Beecham Corp |
Pyrrolidine als dipeptidyl peptidase inhibitoren
|
|
CN1723196A
(zh)
|
2001-06-27 |
2006-01-18 |
史密丝克莱恩比彻姆公司 |
作为二肽酶抑制剂的氟代吡咯烷
|
|
FI20011466A0
(fi)
|
2001-07-04 |
2001-07-04 |
Orion Corp |
Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö
|
|
EP1492525A2
(en)
|
2001-08-16 |
2005-01-05 |
Probiodrug AG |
Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
|
|
JP4337138B2
(ja)
|
2001-08-31 |
2009-09-30 |
味の素株式会社 |
新規ジアリールアルケン誘導体及び新規ジアリールアルカン誘導体
|
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
|
GB0125446D0
(en)
*
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
|
GB0125445D0
(en)
*
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
|
US6861440B2
(en)
*
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
JP2005507261A
(ja)
|
2001-10-31 |
2005-03-17 |
ノバルティス アクチエンゲゼルシャフト |
Ｔｃｆ１遺伝子における多型に基づく糖尿病および関連状態の治療方法
|
|
EP1442028A4
(en)
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
|
US20050101638A1
(en)
*
|
2002-11-08 |
2005-05-12 |
Webb Randy L. |
Combination of organic compounds
|
|
US20030114389A1
(en)
|
2001-11-13 |
2003-06-19 |
Webb Randy Lee |
Combination of organic compounds
|
|
EP2316470A3
(en)
*
|
2001-11-26 |
2011-08-24 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
|
ES2297029T3
(es)
|
2001-12-03 |
2008-05-01 |
F. Hoffmann-La Roche Ag |
Derivados de aminotetralina como antagonistas de receptores muscarinicos.
|
|
GB0129988D0
(en)
|
2001-12-14 |
2002-02-06 |
Ferring Bv |
Imidazolidineacetic acid derivatives
|
|
WO2003054228A2
(en)
|
2001-12-21 |
2003-07-03 |
Axxima Pharmaceuticals Ag |
Human cellular enzymes as targets against hepatitis c virus infections
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
|
WO2003063903A2
(en)
|
2002-02-01 |
2003-08-07 |
Probiodrug Ag |
Modulation of t lymphocytes using dp iv inhibitors
|
|
CA2479812A1
(en)
|
2002-02-28 |
2003-09-04 |
Prosidion Ltd. |
Glutaminyl based dpiv inhibitors
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
DE10211555A1
(de)
|
2002-03-15 |
2003-10-02 |
Imtm Inst Fuer Medizintechnolo |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen
|
|
TW200810743A
(en)
*
|
2002-03-22 |
2008-03-01 |
Novartis Ag |
Combination of organic compounds
|
|
JPWO2003091211A1
(ja)
|
2002-03-28 |
2005-09-02 |
住友製薬株式会社 |
新規ヘテロアリール化合物
|
|
JP4329382B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP4329381B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
WO2003084940A1
(en)
*
|
2002-04-08 |
2003-10-16 |
Alangudi Sankaranarayanan |
Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
|
|
US20040106802A1
(en)
*
|
2002-04-08 |
2004-06-03 |
Torrent Pharmaceuticals Ltd. |
Novel compounds and therapeutic uses thereof
|
|
WO2003095425A1
(en)
|
2002-05-09 |
2003-11-20 |
Taisho Pharmaceutical Co.,Ltd. |
Cyanopyrrolidine derivatives
|
|
JP2004026820A
(ja)
|
2002-05-09 |
2004-01-29 |
Taisho Pharmaceut Co Ltd |
ジペプチジルペプチダーゼｉｖ阻害剤
|
|
US7057046B2
(en)
*
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
WO2003101445A1
(en)
|
2002-06-03 |
2003-12-11 |
Activbiotics, Inc. |
Intravenous rifalazil formulation and methods of use thereof
|
|
ATE422884T1
(de)
|
2002-06-03 |
2009-03-15 |
Novartis Pharma Gmbh |
Verwendung von substituierten cyanopyrrolidinen zur behandlung von hyperlipidämie
|
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
|
WO2004004661A2
(en)
|
2002-07-09 |
2004-01-15 |
Point Therapeutics, Inc. |
Boroproline compound combination therapy
|
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
|
GB0217783D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
|
EP1539748A1
(en)
|
2002-07-31 |
2005-06-15 |
Smithkline Beecham Corporation |
2-phenylpyridin-4-yl derivatives as alk5 inhibitors
|
|
GB0217780D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
|
GB0217786D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
|
TW200404796A
(en)
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
|
KR100582141B1
(ko)
|
2002-08-29 |
2006-05-22 |
다이쇼 세이야꾸 가부시끼가이샤 |
4-플루오로-2-시아노피롤리딘 유도체 벤젠술폰산염
|
|
ATE461212T1
(de)
|
2002-09-18 |
2010-04-15 |
Prosidion Ltd |
Sekundäre bindungsstelle von dipeptidylpeptidase iv (dp iv)
|
|
US20040058876A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Torsten Hoffmann |
Secondary binding site of dipeptidyl peptidase IV (DP IV)
|
|
US7238724B2
(en)
|
2002-09-19 |
2007-07-03 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US20040121964A1
(en)
|
2002-09-19 |
2004-06-24 |
Madar David J. |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
ATE469645T1
(de)
|
2002-10-23 |
2010-06-15 |
Bristol Myers Squibb Co |
Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
|
|
WO2004042533A2
(en)
|
2002-11-01 |
2004-05-21 |
Prominence Networks, Inc. |
End-to-end qos internet protocol
|
|
CA2504735C
(en)
|
2002-11-07 |
2009-06-23 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1422293A1
(en)
|
2002-11-25 |
2004-05-26 |
F. Hoffmann-La Roche Ag |
Crystal structure of dipeptidyl peptidase IV
|
|
AU2002952946A0
(en)
|
2002-11-27 |
2002-12-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
WO2004050022A2
(en)
|
2002-12-04 |
2004-06-17 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
ATE404191T1
(de)
|
2002-12-10 |
2008-08-15 |
Novartis Pharma Ag |
Kombinationen von einem dpp-iv inhibitor und einem ppar- alpha agonist
|
|
US20040121994A1
(en)
|
2002-12-20 |
2004-06-24 |
Anderson Steven N. |
Novel amides that activate soluble guanylate cyclase
|
|
US20040192680A1
(en)
|
2002-12-20 |
2004-09-30 |
Anderson Steven N. |
Novel amides that activate soluble guanylate cyclase
|
|
JP2004244412A
(ja)
|
2003-01-20 |
2004-09-02 |
Kotobuki Seiyaku Kk |
４位に置換基を有する２−シアノピロリジン誘導体及びその製造方法並びにそれを含有する薬剤
|
|
JP4184378B2
(ja)
|
2003-01-31 |
2008-11-19 |
株式会社三和化学研究所 |
ジペプチジルペプチダーゼｉｖを阻害する化合物
|
|
WO2004076433A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
WO2004076434A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
DE10309005A1
(de)
|
2003-03-01 |
2004-09-09 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen, die Dipetidyl Peptidase (DPPIV) und Neurale Endopeptidase (NEP) inhibieren
|
|
CA2518398A1
(en)
|
2003-03-10 |
2004-09-23 |
Schering Corporation |
Heterocyclic kinase inhibitors: methods of use and synthesis
|
|
WO2004092128A1
(en)
|
2003-04-10 |
2004-10-28 |
Smithkline Beecham Corporation |
Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
|
|
WO2004089362A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
2-cyanopyrroles and their analogues as ddp-iv inhibitors
|
|
PE20050021A1
(es)
|
2003-04-16 |
2005-03-15 |
Novartis Ag |
Procedimiento para la preparacion de 2-cianopirrolidina n-sustituida
|
|
US20050014747A1
(en)
*
|
2003-04-18 |
2005-01-20 |
Emily Reinhard |
Dihydrothiazine prodrugs of thiazolium agents
|
|
WO2004098591A2
(en)
|
2003-05-05 |
2004-11-18 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
|
|
EP1961416B1
(en)
*
|
2003-05-05 |
2013-01-23 |
Probiodrug AG |
Use of inhibitors of glutaminyl cyclase for treating psoriasis, rheumatoid arthritis or atherosclerosis.
|
|
MXPA05011922A
(es)
|
2003-05-07 |
2006-02-17 |
Pfizer Prod Inc |
Ligandos del receptor de cannabinoides y sus usos.
|
|
AU2003902260A0
(en)
|
2003-05-09 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
JP2007511467A
(ja)
|
2003-05-14 |
2007-05-10 |
タケダ サン ディエゴ インコーポレイテッド |
ジペプチジルペプチダーゼインヒビター
|
|
WO2004101514A1
(ja)
|
2003-05-15 |
2004-11-25 |
Taisho Pharmaceutical Co., Ltd. |
シアノフルオロピロリジン誘導体
|
|
CN1798556A
(zh)
*
|
2003-06-06 |
2006-07-05 |
麦克公司 |
作为治疗或者预防糖尿病的二肽基肽酶抑制剂的稠合吲哚
|
|
US7235662B2
(en)
|
2003-06-11 |
2007-06-26 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
CN1809544A
(zh)
|
2003-06-17 |
2006-07-26 |
麦克公司 |
作为二肽基肽酶抑制剂用于治疗或预防糖尿病的环己基甘氨酸衍生物
|
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
|
WO2005000848A1
(en)
|
2003-06-20 |
2005-01-06 |
F. Hoffmann-La Roche Ag |
Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors
|
|
JP2005023038A
(ja)
|
2003-07-04 |
2005-01-27 |
Taisho Pharmaceut Co Ltd |
慢性腎疾患治療薬
|
|
DE10330842A1
(de)
|
2003-07-08 |
2005-02-10 |
Institut für Medizintechnologie Magdeburg GmbH, IMTM |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit Hyperproliferation und veränderten Differenzierungszuständen von Fibroblasten
|
|
ATE411980T1
(de)
|
2003-07-21 |
2008-11-15 |
Smithkline Beecham Corp |
(2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl) l-phenylalanylü-2-pyrrolidincarbonitril-p- toluolsulfonsäuresalz und wasserfreie kristalline formen davon
|
|
JP2005047853A
(ja)
|
2003-07-29 |
2005-02-24 |
Fuji Photo Film Co Ltd |
含窒素ヘテロ環化合物の製造方法
|
|
US6995183B2
(en)
*
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
DE10337074A1
(de)
*
|
2003-08-12 |
2005-03-17 |
Keyneurotek Ag |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention von chronischen neurodegenerativen Erkrankungen
|
|
JPWO2005016880A1
(ja)
|
2003-08-18 |
2007-11-01 |
大正製薬株式会社 |
ｃｉｓ−４−フルオロ−Ｌ−プロリン誘導体の製造法
|
|
HU227684B1
(en)
*
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
GB0321295D0
(en)
|
2003-09-11 |
2003-10-15 |
Spirogen Ltd |
Synthesis of protected pyrrolobenzodiazepines
|
|
US7371759B2
(en)
*
|
2003-09-25 |
2008-05-13 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
BR0318533A
(pt)
|
2003-10-06 |
2006-09-12 |
Torrent Pharmaceuticals Ltd |
azolidinacarbonitrilas e seu uso como inibidores de dpp-iv
|
|
US20050153885A1
(en)
|
2003-10-08 |
2005-07-14 |
Yun Anthony J. |
Treatment of conditions through modulation of the autonomic nervous system
|
|
WO2005037826A1
(en)
*
|
2003-10-17 |
2005-04-28 |
Incyte Corporation |
Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
|
|
US20070123470A1
(en)
|
2003-10-24 |
2007-05-31 |
Wladimir Hogenhuis |
Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue
|
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
|
KR20060108692A
(ko)
|
2003-10-31 |
2006-10-18 |
알자 코포레이션 |
메트포르민의 개선된 흡수를 위한 조성물 및 제형
|
|
US20050171112A1
(en)
|
2003-11-03 |
2005-08-04 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
|
AU2004290499C1
(en)
|
2003-11-03 |
2011-02-24 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
|
AU2004286857A1
(en)
|
2003-11-04 |
2005-05-19 |
Merck & Co., Inc. |
Fused phenylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
JP2005139107A
(ja)
|
2003-11-05 |
2005-06-02 |
Taisho Pharmaceut Co Ltd |
ジペプチジルペプチダーゼｉｖ阻害剤
|
|
WO2005049022A2
(en)
|
2003-11-17 |
2005-06-02 |
Novartis Ag |
Use of dipeptidyl peptidase iv inhibitors
|
|
US20070149451A1
(en)
|
2003-11-17 |
2007-06-28 |
Holmes David G |
Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
|
|
ATE517861T1
(de)
|
2003-11-24 |
2011-08-15 |
Merck Sharp & Dohme |
Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
|
|
WO2005058887A1
(en)
|
2003-12-08 |
2005-06-30 |
F. Hoffmann-La Roche Ag |
Novel thiazole derivates
|
|
US7771336B2
(en)
|
2003-12-12 |
2010-08-10 |
Mitsubishi Heavy Industries, Ltd |
Folder for rotary press
|
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
|
US7326728B2
(en)
|
2004-01-16 |
2008-02-05 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof
|
|
US7605264B2
(en)
|
2004-01-16 |
2009-10-20 |
Bristol-Myers Squibb Company |
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
RU2766487C2
(ru)
|
2004-01-20 |
2022-03-15 |
Новартис Аг |
Композиция и способ прямого прессования
|
|
WO2005073186A1
(ja)
|
2004-01-29 |
2005-08-11 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
|
US7230002B2
(en)
|
2004-02-03 |
2007-06-12 |
Glenmark Pharmaceuticals Ltd. |
Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
|
|
CA2554809C
(en)
|
2004-02-05 |
2014-04-29 |
Probiodrug Ag |
Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
|
|
AU2005210285B2
(en)
|
2004-02-05 |
2008-01-24 |
Kyorin Pharmaceutical Co., Ltd. |
Bicycloester derivative
|
|
EP1717225A4
(en)
|
2004-02-18 |
2009-10-21 |
Kyorin Seiyaku Kk |
BICYCLIC AMID DERIVATIVES
|
|
KR20060124712A
(ko)
|
2004-02-20 |
2006-12-05 |
노파르티스 아게 |
신경퇴행 및 인지 장애를 치료하기 위한 ｄｐｐ ⅳ 억제제
|
|
WO2005087235A1
(en)
*
|
2004-03-09 |
2005-09-22 |
National Health Research Institutes |
Pyrrolidine compounds
|
|
KR20080000665A
(ko)
*
|
2005-04-22 |
2008-01-02 |
알란토스 파마슈티컬즈 홀딩, 인코포레이티드 |
디펩티딜 펩티다아제-ⅳ 억제제
|